Orange Book product · Brand (NDA)
ARAKODA
TAFENOQUINE SUCCINATE
At a glance
Aug 08, 2018
Approved
Brand (NDA)
Application
Not listed
TE code
4
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 08, 2018
8 yr ago
Today
Patent 10342791 expires
Listed method-of-use patent (U-2582) expiration.
Dec 02, 2035
in 9 yr 7 mo
Patent 10888558 expires
Listed method-of-use patent (U-2582) expiration.
Dec 02, 2035
in 9 yr 7 mo
Patent 11744828 expires
Listed method-of-use patent (U-2582) expiration.
Dec 02, 2035
in 9 yr 7 mo
Patent 12616689 expires
Listed method-of-use patent (U-2582) expiration.
Dec 02, 2035
in 9 yr 7 mo
Pharmaceutical detail
Active ingredient
TAFENOQUINE SUCCINATE
Strength
EQ 100MG BASE
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 210607
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (4)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10342791 | Dec 02, 2035 | in 9 yr 7 mo | U-2582 |
| 10888558 | Dec 02, 2035 | in 9 yr 7 mo | U-2582 |
| 11744828 | Dec 02, 2035 | in 9 yr 7 mo | U-2582 |
| 12616689 | Dec 02, 2035 | in 9 yr 7 mo | U-2582 |
